Healthcare - Biotechnology - NASDAQ - US
$ 1.32
-6.38 %
$ 1.86 M
Market Cap
-0.13
P/E
CASH FLOW STATEMENT
-12.7 M
OPERATING CASH FLOW
0
INVESTING CASH FLOW
11 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Allarity Therapeutics, Inc.
| Net Income | -11.9 M |
| Depreciation & Amortization | 37 K |
| Capital Expenditures | 0 |
| Stock-Based Compensation | -71 K |
| Change in Working Capital | 3.35 M |
| Others | -3.07 M |
| Free Cash Flow | -12.7 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (11.9) | (16.1) | (26.6) | (5.1) | (14.4) |
| Depreciation & Amortization | 37 K | 60 K | 0.1 | 46 K | 51 K |
| Deferred Income Tax | 97 K | (1.6) | 20 K | (1.3) | (3.8) |
| Stock Based Compensation | 71 K | 1.8 | 6.4 | 0.6 | 0.3 |
| Other Operating Activities | (4.3) | (0.6) | (0.5) | (2.0) | 5.6 |
| Change in Working Capital | 3.4 | (0.3) | 5.6 | 0.4 | 2.1 |
| Cash From Operations | (12.7) | (16.8) | (15.1) | (7.3) | (10.1) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | 0 | 18 K | 0 | 3 K | 8 K |
| Other Items | 0 | 0.8 | 1.0 | 0 | 0.2 |
| Cash From Investing Activities | 0 | 0.8 | 1.0 | 3 K | 0.2 |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | (6.7) | (1.5) | 0 | 0 | 0 |
| Total Debt Repaid | (2.6) | 1.0 | 1.0 | 2.6 | 3.5 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (3.3) | (2.3) | 0.7 | (0.2) | (5.9) |
| Cash From Financing Activities | 11.0 | (1.3) | 33.8 | 6.0 | 11.2 |
| CHANGE IN CASH | |||||
| Net Change In Cash | (1.9) | (17.5) | 19.3 | (1.2) | 1.3 |
| FREE CASH FLOW | |||||
| Free Cash Flow | (12.7) | (16.8) | (15.1) | (7.3) | (10.1) |